LeonaBio, Inc. Severance Costs
LeonaBio, Inc. (LONA) reported Severance Costs of $2.89 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2025-02-27
- LeonaBio, Inc. severance costs for the quarter ending 2024-12-31 was $571.00K.
- LeonaBio, Inc. severance costs for fiscal 2024 was $2.89M.
| Period end | Severance Costs 3 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|
| 2024-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.89M 10-K · filed 2025-02-27 | |
| 2024-09-30 | $2.32M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |